Literature DB >> 11297573

Middle-aged men show higher sensitivity of sleep to the arousing effects of corticotropin-releasing hormone than young men: clinical implications.

A N Vgontzas1, E O Bixler, A M Wittman, K Zachman, H M Lin, A Vela-Bueno, A Kales, G P Chrousos.   

Abstract

The prevalence of insomnia associated with emotional stress increases markedly in middle-age. Both the top and end hormones of the hypothalamic-pituitary-adrenal axis, i.e. CRH and glucocorticoids, stimulate arousal/wakefulness and inhibit slow wave (deep) sleep in experimental animals and man. The objective of this study was to test the hypothesis that middle-age is characterized by increased sensitivity to the sleep-disturbing effects of the hypothalamic-pituitary-adrenal axis. We studied 12 healthy middle-aged (45.1 +/- 4.9) and 12 healthy young (22.7 +/- 2.8) men by monitoring their sleep by polysomnography for 4 consecutive nights, including in tandem 1 adaptation and 2 baseline nights and a night during which we administered equipotent doses of ovine CRH (1 microg/kg, iv bolus) 10 min after sleep onset. Analyses included comparisons within and between groups using multiple ANOVA and regression analysis. Although both middle-aged and young men responded to CRH with similar elevations of ACTH and cortisol, the former had significantly more wakefulness and suppression of slow wave sleep compared with baseline sleep; in contrast, the latter showed no change. Also, comparison of the change in sleep patterns from baseline to the CRH night in the young men to the respective change observed in middle-aged men showed that middle-age was associated with significantly higher wakefulness and significantly greater decrease in slow wave sleep than in young age. We conclude that middle-aged men show increased vulnerability of sleep to stress hormones, possibly resulting in impairments in the quality of sleep during periods of stress. We suggest that changes in sleep physiology associated with middle-age play a significant role in the marked increase of prevalence of insomnia in middle-age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297573     DOI: 10.1210/jcem.86.4.7370

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Insomnia with Short Sleep Duration: Nosological, Diagnostic, and Treatment Implications.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza
Journal:  Sleep Med Clin       Date:  2013-09-01

Review 2.  Insomnia and its impact on physical and mental health.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

4.  Risk factors for incident chronic insomnia: a general population prospective study.

Authors:  Ravi Singareddy; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Susan Calhoun; Michele L Shaffer; Edward O Bixler
Journal:  Sleep Med       Date:  2012-03-17       Impact factor: 3.492

5.  Effects of Insufficient Sleep on Pituitary-Adrenocortical Response to CRH Stimulation in Healthy Men.

Authors:  Aurore Guyon; Lisa L Morselli; Marcella L Balbo; Esra Tasali; Rachel Leproult; Mireille L'Hermite-Balériaux; Eve Van Cauter; Karine Spiegel
Journal:  Sleep       Date:  2017-06-01       Impact factor: 5.849

Review 6.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

Review 7.  A closed literature-based discovery technique finds a mechanistic link between hypogonadism and diminished sleep quality in aging men.

Authors:  Christopher M Miller; Thomas C Rindflesch; Marcelo Fiszman; Dimitar Hristovski; Dongwook Shin; Graciela Rosemblat; Han Zhang; Kingman P Strohl
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

8.  Excessive daytime sleepiness in sleep disorders.

Authors:  Gemma Slater; Joerg Steier
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

9.  CHRONIC INSOMNIA AND STRESS SYSTEM.

Authors:  Maria Basta; George P Chrousos; Antonio Vela-Bueno; Alexandros N Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

10.  Effects of sleep fragmentation on sleep and markers of inflammation in mice.

Authors:  Rita A Trammell; Steve Verhulst; Linda A Toth
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.